Trial of diagnosing carotid or aortic plaque using ultrasound contrast agent

Trial of diagnosing carotid or aortic plaque using ultrasound contrast agent - Trial of diagnosing carotid or aortic plaque using ultrasound contrast agent

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006361

Enrollment

Registered

2011-10-01

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid stenosis aortic complicated lesions

Interventions

Perflubutane 0.010ml/kg-0.020ml/kg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a.The patients who have carotid stenosis b.The patients who have aortic complicated lesions

Exclusion criteria

Exclusion criteria: a.The patients that we cannot get written informed consent. b.The patients who are allergic to egg.

Design outcomes

Primary

Measure	Time frame
The differences between the positive plaques and negative plaques	—

Secondary

Measure	Time frame
The difference of outcome of the patient with the positive plaques and negative plaques	—

Countries

Japan

Contacts

Public ContactYuka Terasawa

Tokushima University Department of Clinical Neuroscience

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026